Table 2.
Clinical Outcome | Infection Status | Cases | Person-Years | Incidence Rate (95% CI) | Unadjusted hazard ratio (95% CI) |
---|---|---|---|---|---|
Cirrhosis | HCV mono-infected | 11,369 | 652,344 | 17.43 (17.11 – 17.75) | 1.00 |
| |||||
HBV co-infected, DNA + | 58 | 1,575 | 36.82 (28.46–47.62) | 2.15 (1.66–2.79) | |
HBV co-infected, DNA − | 55 | 2,571 | 21.39 (16.42–27.86) | 1.22 (0.94–1.59) | |
| |||||
HCC | HCV mono-infected | 2,613 | 717,052 | 3.64 (3.51 – 3.79) | 1.00 |
| |||||
HBV co-infected, DNA + | 14 | 2,041 | 6.86 (4.06–11.58) | 1.97 (1.16–3.33) | |
HBV co-infected, DNA − | 15 | 2,895 | 5.18 (3.12–8.59) | 1.38 (0.83–2.29) | |
| |||||
Death | HCV mono-infected | 25,334 | 805,036 | 31.47 (31.08 – 31.86) | 1.00 |
| |||||
HBV co-infected, DNA + | 95 | 2,277 | 41.72 (34.12–51.02) | 1.37 (1.12–1.67) | |
HBV co-infected, DNA − | 97 | 3,214 | 30.18 (24.73–36.82) | 0.95 (0.77–1.15) |